KRS Capital Management’s Humana HUM Stock Holding History

KRS Capital Management’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-48	Closed	-$22K	–	220
2021 Q4	$22K	Buy	+48	New	+$21.2K	0.02%	284

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KRS Capital Management's HUM Position: Q1 2022 in Review

KRS Capital Management sold out of Humana (HUM) in Q1 2022, closing a stake of 48 shares — an estimated $22K sold.

KRS Capital Management first reported a position in HUM in Q4 2021 and held it in 1 quarter. The position peaked at $22K in Q4 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

KRS Capital Management reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
KRS Capital Management sold 48 Humana shares in Q1 2022, an estimated $22K.
KRS Capital Management first reported a position in Humana in Q4 2021 and held it in 1 quarter.
KRS Capital Management's Humana position peaked at $22K in Q4 2021.
914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.